ABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Peritoneal Dialysis/methods , Psychotropic Drugs/administration & dosage , Anxiety/drug therapy , Depression/drug therapy , Sleep Initiation and Maintenance Disorders/drug therapyABSTRACT
No disponible
No disponible
Subject(s)
Humans , Male , Middle Aged , Polycystic Kidney Diseases/complications , Pancreatitis, Acute Necrotizing/complications , Renal Dialysis , Fatty Liver/complicationsABSTRACT
No disponible
No disponible
Subject(s)
Humans , Peritoneal Dialysis/methods , Disinfection/methods , Asepsis/methods , Dialysis Solutions/analysisABSTRACT
No disponible
No disponible
Subject(s)
Humans , Male , Middle Aged , Granulomatosis with Polyangiitis/complications , Lung Neoplasms/complications , Renal Insufficiency, Chronic/therapy , Renal DialysisABSTRACT
La incidencia de hemoperitoneo en diálisis varia del 6% hasta el 57% en mujeres premenopáusicas. El sangrado peritoneal puede ser el resultado de un proceso relacionado con la diálisis ono estar relacionado con la enfermedad renal. La endocarditis de Libman-Sacks se describió por primera vez en1924, se caracteriza por lesiones de tipo verrugoso implantadas en las superficies valvulares y está íntimamente ligada a la presencia de anticuerpos antifosfolípido. Enviamos el caso de una paciente en programa de Diálisis peritoneal que presentó una endocarditis de Libman-Sacks, y cursó con hemoperitoneo (AU)
The incidence of hemoperitoneum varies from 6% to 57% in premenopausal women. Bloody peritoneal dialysate maybe the result of the peritoneal dialysis procedure or may be due to factors unrelated to renal disease. The Libman-Sacks endocarditis was described for the first time in 1924, is characterized for verrucous lesions in the surfaces valves and has been intimately associated with the presence of antiphospholipid antibodies. We send a case of a patient in program of Dialysis peritoneal that presented an Libman-Sacks endocarditis and hemoperitoneum (AU)
Subject(s)
Humans , Female , Middle Aged , Hemoperitoneum/complications , Endocarditis/complications , Renal Insufficiency, Chronic/therapy , Peritoneal Dialysis , Antibodies, Antiphospholipid/isolation & purificationABSTRACT
El quiloperitoneo es una entidad rara en diálisis peritoneal. Se ha descrito en pacientes diagnosticados de amiloidosis sistémica. Presentamos el caso de una paciente en programa de diálisis peritoneal, con amiloidosis familiar tipo enfermedad de Andrade que cursó con quiloperitoneo intermitente y recidivante (AU)
Chyloperitoneum is very infrequent in peritoneal dialysis. It has been described in patients diagnosed of systemic amyloidosis. We present the case of a patient in program of peritoneal dialysis, with familial amyloidosis type Andrade disease that presented intermittent and recidivante chyloperitoneum (AU)
